To test the effect of LAMP1‐KD and 144DG11 on fuel utilization, we again used the ATP Rate Assay (Fig 4) in LAMP1‐KD and control APBD fibroblasts acutely or chronically treated with 144DG11. Here, LAMP1 is linked to adult polyglucosan body disease.